CE vs TARA · rev $5.09B vs $228.8M cap
Celanese Corporation (CE) versus Protara Therapeutics Inc (TARA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Protara Therapeutics Inc (TARA) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
TARA does not have a complete income-statement cache yet.
CE currently screens at market cap $5.92B. TARA currently screens at market cap $228.8M.
Not investment advice. Open the CE and TARA stock pages for the full models.
Not investment advice.